For a cost-effective translation without cell manipulation, we then combined ALT-803, which is an IL-15 superagonist that promotes expansion of T cells57 in vivo (Supplementary Fig. 25A–C), with BC281 or BC462 in the MLL-AF9 leukemia model. Here, KMT2A is linked to leukemia.